BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28985507)

  • 1. Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity.
    Chen YC; Farzadfard F; Gharaei N; Chen WCW; Cao J; Lu TK
    Mol Cell; 2017 Oct; 68(1):247-257.e5. PubMed ID: 28985507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Screening Approach for the Dissection of Cellular Regulatory Networks of NF-κB Using Arrayed CRISPR gRNA Libraries.
    O'Shea P; Wildenhain J; Leveridge M; Revankar C; Yang JP; Bradley J; Firth M; Pilling J; Piper D; Chesnut J; Isherwood B
    SLAS Discov; 2020 Jul; 25(6):618-633. PubMed ID: 32476557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons.
    Santhosh Kumar S; Naseri NN; Pather SR; Hallacli E; Ndayisaba A; Buenaventura C; Acosta K; Roof J; Fazelinia H; Spruce LA; Luk K; Khurana V; Rhoades E; Shalem O
    Sci Adv; 2024 Feb; 10(6):eadj4767. PubMed ID: 38335281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting off-targeting in guide-RNAs for CRISPR systems for simultaneous editing of multiple genes.
    Ferreira R; Gatto F; Nielsen J
    FEBS Lett; 2017 Oct; 591(20):3288-3295. PubMed ID: 28884816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart.
    Schoger E; Carroll KJ; Iyer LM; McAnally JR; Tan W; Liu N; Noack C; Shomroni O; Salinas G; Groß J; Herzog N; Doroudgar S; Bassel-Duby R; Zimmermann WH; Zelarayán LC
    Circ Res; 2020 Jan; 126(1):6-24. PubMed ID: 31730408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
    Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
    Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-scale CRISPR interference guide library enables comprehensive phenotypic profiling in yeast.
    McGlincy NJ; Meacham ZA; Reynaud KK; Muller R; Baum R; Ingolia NT
    BMC Genomics; 2021 Mar; 22(1):205. PubMed ID: 33757429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SeqCor: correct the effect of guide RNA sequences in clustered regularly interspaced short palindromic repeats/Cas9 screening by machine learning algorithm.
    Liu X; Yang Y; Qiu Y; Reyad-Ul-Ferdous M; Ding Q; Wang Y
    J Genet Genomics; 2020 Nov; 47(11):672-680. PubMed ID: 33451939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
    Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
    J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular synthesized CRISPR/Cas gRNAs for functional interrogations in the coding and noncoding genome.
    Wegner M; Diehl V; Bittl V; de Bruyn R; Wiechmann S; Matthess Y; Hebel M; Hayes MG; Schaubeck S; Benner C; Heinz S; Bremm A; Dikic I; Ernst A; Kaulich M
    Elife; 2019 Mar; 8():. PubMed ID: 30838976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies.
    Jensen ED; Ferreira R; Jakočiūnas T; Arsovska D; Zhang J; Ding L; Smith JD; David F; Nielsen J; Jensen MK; Keasling JD
    Microb Cell Fact; 2017 Mar; 16(1):46. PubMed ID: 28298224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering.
    Ui-Tei K; Maruyama S; Nakano Y
    Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Genomics via CRISPR-Cas.
    Ford K; McDonald D; Mali P
    J Mol Biol; 2019 Jan; 431(1):48-65. PubMed ID: 29959923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design.
    Smith JD; Suresh S; Schlecht U; Wu M; Wagih O; Peltz G; Davis RW; Steinmetz LM; Parts L; St Onge RP
    Genome Biol; 2016 Mar; 17():45. PubMed ID: 26956608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening Regulatory Element Function with CRISPR/Cas9-based Epigenome Editing.
    Klann TS; Crawford GE; Reddy TE; Gersbach CA
    Methods Mol Biol; 2018; 1767():447-480. PubMed ID: 29524151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
    Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
    Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced scale and scope of genome engineering and regulation using CRISPR/Cas in Saccharomyces cerevisiae.
    Deaner M; Alper HS
    FEMS Yeast Res; 2019 Nov; 19(7):. PubMed ID: 31665284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Mediated Generation of Guangxi Bama Minipigs Harboring Three Mutations in α-Synuclein Causing Parkinson's Disease.
    Zhu XX; Zhong YZ; Ge YW; Lu KH; Lu SS
    Sci Rep; 2018 Aug; 8(1):12420. PubMed ID: 30127453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library.
    Koike-Yusa H; Li Y; Tan EP; Velasco-Herrera Mdel C; Yusa K
    Nat Biotechnol; 2014 Mar; 32(3):267-73. PubMed ID: 24535568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.